• Skip to main content
  • Skip to footer

Life Sciences British Columbia

  • Newsletters |
  • Members Area |
  • Contact
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Programs
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login

Takeda Canada Inc.

Member Profile

Takeda Canada was established April 1, 2009 as part of a significant global expansion by Takeda Pharmaceutical Company Limited, a research-based global pharmaceutical company with a 250-year heritage. Takeda is the largest pharmaceutical company in Japan and one of the top 20 pharmaceutical companies worldwide. Takeda Canada’s goal is to bring important medicines to Canadians who need them.

Sector
Biotechnology, Global Pharmaceutical Corporations, Therapeutics
Area of Expertise
  • Bioinformatics
  • Bioprocessing
  • Bioproducts
  • Cellular Medicine
  • Distributor
  • Drug Delivery
  • Drug Discovery
  • Neurophysiology
  • Oncology
  • Product Development
Company Stage Commercial Stage, Public Company
Stock Ticker 4502 - TYO

Member Profile

Biotechnology, Global Pharmaceutical Corporations, Therapeutics

Takeda Canada Inc.

Bronze Sponsor

  • Website www.takedacanada.com
  • Phone +1 (866) 397 4473
  • Email info@takedacanada.com
  • Address
    Bay Adelaide Centre, 22 Adelaide St W Suite 3800
    Toronto, ON
    M5H 4E3
  • Leadership Contact
    Matt Lee, Director, Market Access
    Follow us:
  • Twitter
  • Facebook
  • LinkedIn
  • News
  • Jobs

June 22, 2023

INESSS Recommends LIVTENCITY™ (maribavir) for Public Reimbursement in Quebec

June 1, 2023

Takeda Opens Digital Health Innovation Challenge in Partnership with Plug and Play Alberta for Solutions to Improve Patient Care in Inflammatory Bowel Disease

May 11, 2023

Takeda Presents Real-World Clinical Effectiveness and Safety Results of Vedolizumab (ENTYVIO®) and Ustekinumab as First-Line Biologic Treatment for Crohn’s Disease

April 20, 2023

Takeda has Secured Three-Year Contract in Key Immunoglobulin Category

March 30, 2023

Takeda Announces Results from Phase 4 Vedolizumab Study in Patients with Chronic Pouchitis Published in New England Journal of Medicine

No current content.

  • Twitter
  • Linkedin
Tweets by Takeda Canada Inc.
Connect with us LinkedIn

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us